Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Addressing the rise of multiple myeloma in Rwanda

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda

Addressing the rise of multiple myeloma in Rwanda ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )

Revolving door between the regulators and industry

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Revolving door between the regulators and industry ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Perspectives on advance care planning for advanced cancer in the Philippines

Dr Sachiko Estreller - Cordillera Hospital of the Divine Grace, Benguet...

Perspectives on advance care planning for advanced cancer in the Philippines ( Dr Sachiko Estreller - Cordillera Hospital of the Divine Grace, Benguet, Philippines )

Durable responses in aRCC, how do we optimise treatment?

Prof Roberto Iacovelli and Prof Viktor Grünwald

Durable responses in aRCC, how do we optimise treatment? ( Prof Roberto Iacovelli and Prof Viktor Grünwald )

Bladder cancer updates from the first half of 2024

Prof Alison Birtle, Dr Ignacio Durán, Dr Patrizia Giannatempo

Bladder cancer updates from the first half of 2024 ( Prof Alison Birtle, Dr Ignacio Durán, Dr Patrizia Giannatempo )

The combination of regorafenib, nivolumab and SCRT shows promising efficacy as...

Dr Francesco Sclafani - Institut Jules Bordet, Brussels, Belgium

The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC ( Dr Francesco Sclafani - Institut Jules Bordet, Brussels, Belgium )

Trifluridine/tipiracil followed by regorafenib can be an effective treatment...

Prof Michel Ducreux - Gustave Roussy Cancer Centre, Paris, France

Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC ( Prof Michel Ducreux - Gustave Roussy Cancer Centre, Paris, France )

Preview: World Cancer Congress 2024

Union for International Cancer Control

Preview: World Cancer Congress 2024 ( Union for International Cancer Control )

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful...

Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients ( Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea )

Biomarkers, predictive and prognostic factors of resistance to immunotherapy

Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)...

Biomarkers, predictive and prognostic factors of resistance to immunotherapy ( Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)/Clínica Universidad de Navarra, Spain )

Antibody drug conjugates in lung cancer

Dr Edgardo Santos - The Oncology Institute of Hope & Innovation, Florida, USA

Antibody drug conjugates in lung cancer ( Dr Edgardo Santos - The Oncology Institute of Hope & Innovation, Florida, USA )

Research highlights in gastrointestinal tumours

Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA

Research highlights in gastrointestinal tumours ( Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA )

More from ecancer